MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma
- Resource Type
- Article
- Authors
- Stroh, Jacob ; Seckinger, Anja ; Heider, Michael ; Rudelius, Martina; Eichner, Ruth; Schick, Markus; Slawska, Jolanta; Emde-Rajaratnam, Martina; Salwender, Hans; Bertsch, Uta; Goldschmidt, Hartmut; Weisel, Katja; Scheid, Christof; Keller, Ulrich; Hose, Dirk ; Bassermann, Florian
- Source
- In Blood Advances 25 January 2022 6(2):515-520
- Subject
- Language
- ISSN
- 2473-9529